Cranberries (Vaccinium macrocarpon) and Cardiovascular Disease Risk Factors

Authors: McKay, Diane L.; Blumberg, Jeffrey B.

Source: Nutrition Reviews, Volume 65, Number 11, November 2007 , pp. 490-502(13)

Publisher: International Life Sciences Institute

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

The American cranberry (Vaccinium macrocarpon) is one of the three commercially important fruits native to North America. Cranberries are a particularly rich source of phenolic phytochemicals, including phenolic acids (benzoic, hydroxycinnamic, and ellagic acids) and flavonoids (anthocyanins, flavonols, and flavan-3-ols). A growing body of evidence suggests that polyphenols, including those found in cranberries, may contribute to reducing the risk of cardiovascular disease (CVD) by increasing the resistance of LDL to oxidation, inhibiting platelet aggregation, reducing blood pressure, and via other anti-thrombotic and anti-inflammatory mechanisms. Research regarding the bioactivity of cranberries and their constituents on risk factors for CVD is reviewed.

Keywords: CRANBERRY; VACCINIUM MACROCARPON; FLAVONOID; PROANTHOCYANIDIN; CARDIOVASCULAR DISEASE

Document Type: Research article

DOI: 10.1301/nr.2007.nov.490-502

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$20.00 plus tax Refund Policy